On Wednesday the 2nd of February, Neuro-Bio’s CEO, Susan Greenfield, attended the Hilary dinner at the St John’s college in Oxford. She was invited as a guest speaker and the title of her talk was: “Disruptive discoveries inspired by a basic...
Neuro-Bio welcomes Anton Shmelev as part of the team. Anton hopes to apply his experience in the areas of protein misfolding, receptor trafficking, as well as general protein science and molecular biology into the field of the Alzheimer’s research conducted at...
We are delighted to announce that our seminal paper A novel process driving Alzheimer’s validated in a mouse model: therapeutic potential’ has been accepted by the peer-reviewed journal Alzheimer’s & Dementia: Translational Research & Clinical...
Great success for Neuro-bio’s CEO, Susan Greenfield at the Rosalind Franklin Institute on Thursday 27.01. She talked about the assets that the company is currently working on and had the chance to talk and meet the audience. The Neuro-bio’s team was there...
Neuro-Bio has been mentioned as Global Alzheimer’s Disease Diagnostic Market Key Player by Maximize market research pvt. ltd. To read the full article, click the link.